State of the art = CY obtained by 50% of participants in a widely distributed external survey.
• IBY calculated in our laboratory.
been selected by a laboratory, the imprecision achieved must be determined by replicate analysis of the quality control materials which will subsequently be used to assess assay performance, and Shewhart charts constructed showing ± 2 SO and ± 3 SO. Future analystical batches will be judged acceptable or unacceptable according to rules based upon these figures. Numerical values generated are used both for diagnosis and for monitoring the progress of individual patients. Imprecise methods greatly affect the efficacy of these functions. Using the data provided by Dr Ricos the percentage change between sequential results required for significance (P < 0,05) has been calculated.
Percentage change in sequential results required for significance (P<0·05)
Quality control of interpretation--possibility, necessity or threat Dr Stewart's personal view' poses the question of whether medical audit should be extended to address the quality of the remarks we make on reports which carry the result of tests for which we are responsible. I think that it should, but can forsee that it will be extremely difficult to devise a method for assessing performance in any quality control scheme. This has been demonstrated by the unsatisfactory attempts which have been made to set examination questions on the interpretation of laboratory tests and even less satisfactory attempts at marking the answers.
At the simplest level, a set oflaboratory reports could be circulated to each laboratory with a request for comments. It would be necessary for each report to have sufficient details of the patient and the clinical condition and relevant reference ranges for the listed tests. It should be stipulated that the comments should be roughly the same as those which would be made on similar results from patients. The reports could then be returned to a group of eminent members of the profession for assessment.
This method is unsatisfactory for three main reasons. The quality control reports will not be treated the same as patient's results; they will inevitably be given more careful consideration and cannot be amended in the light of more information obtained by visiting the patient or speaking to his/her clinician. The comments, apart from individual results being outside the quoted reference range or results from stimulation tests being outside approved limits, will not be objective assessments but subjective impressions. Finally, it will be impossible for the 'jury' to score the accuracy of the 
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Of course this implies that goals must be reviewed with the progressive improvement of technology. 
The author replies:
It is recognised that, for some analytes, the methodology and equipment in current use makes it difficult to achieve the desirable imprecision as defined by biological variation. Imprecision so defined must remain the ultimate goal and the target which, by improving methodology and equipment we should strive to achieve. It is important when new methods and equipment are evaluated to determine whether or not defined analytical goals are met and goals derived from biological variation provide objective targets which are unaffected by the performance of earlier analytical methods or equipment. majority of comments and it will therefore not be possible to give a meaningful figure to demonstrate the level of performance.
Any other more complicated methods will run into even more problems. I therefore consider that a national quality assurance scheme for the control of interpretation of results should not be contemplated.
A more realistic method, at a local level, would be for the quality of the comments on biochemistry reports to be judged by the clinicians who request the tests. This is already done informally when we are criticised by our colleagues for putting an interpretation on a set of results which conflicts with the diagnosis or clinical impression. It should be possible to introduce a more formal method by requesting that all such anomalies are reported to the laboratory and perhaps discussed at clinical meetings to see whether any explanation for the discrepancies can be found. This would lead to a better understanding of each other's problems and perhaps an improvement in the quality of remarks on reports which should enhance our contribution to the care of the patient.
While we are on the subject of laboratory reports, it would be interesting to know whether particular laboratories have attempted to improve the quality of information given on their reports. It is known that, following serum levels obtained for therapeutic drug monitoring, some now recommend specific alterations to the dose prescribed; others use the level of tumour markers to recommend changes in cytotoxic drug therapy; lipid levels are often accompanied by advice on classification and treatment. Do any laboratories attempt to give the diagnostic sensitivity and specificity for different degrees of abnormality? Do any use discriminant analysis on batches of tests as a routine? Has anyone developed 'expert' computer programmes to make comments automatically? Perhaps we could also be informed how successful these attempts have been. Correction for haemodilutional changes to plasma albumin concentration
Taggart et al,' have examined the validity of factors utilising packed cell volume (PCV) and Alpha-2 macroglobulin for the correction ofhaemodilutional effects on plasma albumin. They showed in four subjects that the apparently rigorous correction 3 and that using 0:-2 macroglobulin gave similarly unrealistically raised albumin concentrations from 2 h after plasma expansion and surgical injury. We can confirm, in a group of 68 surgical patients, that these corrections also produced unrealistically high results when the patients were not subject to the initial volume expansion of their subjects, but only to the combination of the well-established anti-diuretic effect of trauma and the infusion of nutritional solutions.
PCV and plasma albumin were measured (bromocresol green) preoperatively and on days I, 3, and 5 postoperatively in 68 patients having elective intraabdominal surgery of moderate severity in whom operative blood loss was minimal. The patients received a continuous intravenous infusion of at least 2·5 L per day throughout the period. All patients had normal renal function. Plasma albumin was corrected according to factors I, 2, and 3 as used by Taggart et al. and additionally for changes in haemoglobin (Hb) and the results were as shown in Table I below:
Neither we nor Taggart et al. have measured plasma volume so that the validity in vivo of these corrections cannot be properly assessed but we agree that factor 3 is inappropriate for use with albumin over this time scale and that factors I and 2 give apparently acceptable results. Correction for haemodilution is of importance also when studying the surgical response to protein bound constituents such as triglyceride but has been largely ignored. • Factor I x initial PC".j~e.w PCV; factor 2 x (I-new PCV)j(l-initial PCV); factor 3 x (initial PCV x (I-new PCV»j(new PCV x (I-InitIal PCV)); factor 4 x new Hbjinitial Hb. Hb, blood haemoglobin.
